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most severe cases with pneumonia are not included in this study
as they were treated in ICU.244 15th ICID Abstracts / International Journa
or the diagnosis of actinomicosys. The culture was then posi-
ive forActinomyces israelii. The evolution under treatment with
enicillin G, surgical debridement, antiretroviral treatment and
otrimoxazole was slowly favorable.
Conclusion: The diagnosis and successful management of this
are disease required the collaboration of the infectious diseases
pecialist, surgeon and microbiologist and the clinicians should
e aware of this illness when making the differential diagnosis of
atero-cervical tumors.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.869
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ariations in attack rate in a single-blind, dose escalation chal-
enge study of Salmonella Typhi in healthy adult volunteers
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Background: Typhoid fever causes signiﬁcant morbidity and
ortality worldwide. Efforts to develop novel vaccines that are
uitable for infants and that have improved efﬁcacy over existing
accines has been hindered by poor understanding of protective
mmunity. A human challenge model of typhoid infection, using
ild-type S. Typhi (Quailes strain) suspended in milk, was used
n the 1960-70 s to investigate the pathogencic mechanisms and
o evaluate vaccine candidates, including the live-attenuated oral
accine Ty21a. Subsequent challengemodels of other enteric infec-
ions have used a sodium bicarbonate (NaHCO3) solution to buffer
he effects of gastric acid, giving a more consistent attack rate (AR),
ess inter-individual variation, andpermit lower challenge innocula
o be used.
Methods: Two cohorts of 20 healthy adults were enrolled in
single-blind, dose-escalation, challenge study using S. Typhi
Quailes strain) suspended in a NaHCO3 buffer. Participants
ngested 120mL NaHCO3 solution one minute before
ingesting 1-5×103 (cohort 1) or 1-5×104 (cohort 2) colony
orming units (CFU) of S.Typhi suspended in 30mL NaHCO3 solu-
ion. Daily review, sample collection (including blood and stool for
ulture) and oral temperature measurements were performed for
4-days from challenge. Typhoid feverwas diagnosed in thosewith
ersistent high temperature or bacteraemia. All participants were
reated with ciproﬂoxacin when diagnosed with typhoid fever or
4-days from challenge.
Results: Cohort 1 ingested a median of 1.385×103 CFU (range
05-1880) of S. Typhi; 11/20 participants developed typhoid fever
AR=55%). Cohort 2 ingested a median of 1.9825×104 CFU (range
.550-2.695×104); 13/20 developed typhoid fever (AR=65%).
igher challenge dose was associated with an earlier onset of ill-
ess (mean day of onset of 6.3 (range 4-9) vs. to 8.4 (range 4-13)
espectively). Blood culture detected 87.5% of cases. The earliest
acteraemia detected by blood culutre occured four days post chal-
enge and the latest at day 13 post challenge.fectious Diseases 16S (2012) e158–e316
Conclusion: The use of a NaHCO3 buffer allows infection to
be induced with a lower challenge innoculum than previously
observed in models using a milk buffer. Higher challenge innoc-
ula moderately increases the AR. A 65% AR is feasible, allows the
study of early typhoid pathogenesis and immunobiology and could
accelerate novel vaccine development.
http://dx.doi.org/10.1016/j.ijid.2012.05.870
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Background: In the post pandemic two-years period (2010-
2011), LRTI was one of the main causes for incoming patients and
hospitalizations at our clinic.
Methods: Cumulative number of patients with LRTI (includ-
ing Interstitial viral or bacterial Bronchopneumonia, Pneumonia
or Pleuropneumonia) in 2010 and 2011, was 2458/2387 consec-
utively. In 2010, 1400 were treated as outpatients; 1058 were
hospitalized. In 2011, 1570 were treated as outpatients and 817
were hospitalized. From the total number of hospital healed
patients, 236 and243patientswith LRTIwere treated in years 2010,
2011. This study is focusedon theadult groupofpatients (18-91yrs)
– 187 patients in 2010, (average 49.7 years-old) and 191 patients
in 2011, (average 51 years-old). Among all the hospitalized adult
patients, comorbidities persisted in 69.7% of them (diabetes, HOBB,
CMPchr, obesitas, etc).
Results: In the period of 2010/2011 penumoslide was positive
for IgM for Mycoplasma pn. in 5/4 blood samples; Chlamydia pn. in
4/2; Legionella pn in 3/7; Haemoph. inf. in 4/6; Inﬂuenza A in 7/3.
Haemoculture was positive for Staph. Aureus in 2/2 patients; Strep-
tococcus pn. was detected in 3/2 sputum samples and Str.pyogenes
in 5/4 patients.
Conclusion: The data achieved from blood culture, sputum
samples, pneumoslide, in addition to radiological signs, blood
cell count (leukocytosis with granulocytosis), CRP, sedimentation,
remarkable respond and improvement of patients condition to the
implemented therapy, signiﬁcantly points out the bacterial pre-
dominance for LRT Inﬂammation among hospital treated adult
patients. In 2010, 7 patients had inﬂuenza A pneumonia and 3were
detected in 2011. In the period 2010/2011, 156 (83%) / 169 (88.5%)
patients had Pneumococcal pneumonia. With atypical pneumonia
were treated 16 patients (8.6%) in 2010; 16 patients (9.9%) in 2011.
Staphylococcus aureuswas the cause of LRT inﬂammation in 2 (1.1%)
patients in 2010, and 2 (1%) in 2011. We have to point out that thehttp://dx.doi.org/10.1016/j.ijid.2012.05.871
